Media coverage
1
Media coverage
Title FDA: Roflumilast Foam NDA Accepted for Seborrheic Dermatitis Media name/outlet Drug Topics (MJH) Country/Territory United States Date 1/04/23 URL ct.moreover.com/?a=50566138923&p=1gw&v=1&x=RE9VngjDtsfsvj9_cyR_9w Persons Peter Lio